RecallDepth
Class II Ongoing

Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b) 500-count HDPE bottle (NDC 65862-832-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.

This recall is currently active, issued December 11, 2024. It was issued by Aurobindo Pharma Usa Inc..

Company
Aurobindo Pharma Usa Inc.
Recall Initiated
November 7, 2024
Posted
December 11, 2024
Recall Number
D-0078-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
3336 bottles
Firm Location
East Windsor, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit

Distribution

USA Nationwide

Lot / Code Info

Lot #: a) CFSB23001A, Exp 03/31/2025, CFSB23002A, Exp 07/31/2025; CFSB23003A, Exp 10/31/2025; CFSB23004A, Exp 10/31/2025; b) P2300196, 12/31/2024

More recalls by Aurobindo Pharma Usa Inc.

View all recalls by this company →

Other recent Class II Drug recalls